A. Vinik et al. Normative Values for Electrochemical Skin Conductances and Impact of Ethnicity on Quantitative Assessment of Sudomotor Function. Diabetes Technol Ther. 2016 Jun;18(6):391-8.  Resumen aquí.

L. Leclair-Visonneau et al. (Y. Péréon). Electrochemical skin conductance for quantitative assessment of sweat function: Normative values in children. Clinical Neurophysiology Practice 1 (2016) 43–45. Resumen aquí.
 
L. Bordier et al. (B. Bauduceau). Accuracy of a Rapid and Non-Invasive Method for the Assessment of Small Fiber Neuropathy Based on Measurement of Electrochemical Skin Conductances. Front Endocrinol (Lausanne). 2016 Feb 29;7:18. Resumen aquí.
 
P. Novak. Electrochemical Skin Conductance Correlates with Skin Nerve Fiber Density. Frontiers in Aging Neuroscience. 2016;8.  Resumen aquí.
 
A.G Smith et al. The diagnostic utility of Sudoscan for distal symmetric peripheral neuropathy. Journal of diabetes and its complications vol. 28,4 (2014): 511-6. Resumen aquí.

JP Lefaucheur. The value of electrochemical skin conductance measurement by Sudoscan for assessing autonomic dysfunction in peripheral neuropathies beyond diabetes. J Neurophysiologie Clinique 53 (2023) 102859. Resumen aquí.

K Newlin Lew et al. Diabetes Distal Peripheral Neuropathy: Subtypes and Diagnostic and Screening Technologies. J Diabetes Sci Technol. 2022 Mar;16(2):295-320 (Review with section on Sudoscan).  Resumen aquí.
 
P Novak. Electrochemical skin conductance: a systematic review, Clin Auton Res. 2019 Feb;29(1):17-29. doi: 10.1007/s10286-017-0467-x. Epub 2017 Sep 26. Resumen aquí.

JP Lefaucheur. The value of electrochemical skin conductance measurement by Sudoscan® for assessing autonomic dysfunction in peripheral neuropathies beyond diabetes. Neurophysiol Clin. 2023 Apr;53(2):102859. Resumen aquí.

JP Lefaucheur. Assessment of autonomic nervous system dysfunction associated with peripheral neuropathies in the context of clinical neurophysiology practice. Neurophysiol Clin. 2023 Apr;53(2):102858. Resumen aquí.

Idiaquez J, Casar JC, Fadic R, Iturriaga R. Sympathetic and electrochemical skin responses in the assessment of sudomotor function: a comparative study. Neurophysiol Clin. 2023 Apr;53(2):102840. Resumen aquí.

Gavan DE, Gavan A, Bondor CI, Florea B, Bowling FL, Inceu GV, Colobatiu L. SUDOSCAN, an Innovative, Simple and Non-Invasive Medical Device for Assessing Sudomotor Function. Sensors (Basel). 2022 Oct 6;22(19):7571. Resumen aquí.

K Newlin Lew et al. Diabetes Distal Peripheral Neuropathy: Subtypes and Diagnostic and Screening Technologies. J Diabetes Sci Technol. 2022 Mar;16(2):295-320 (Review with section on Sudoscan). Resumen aquí.

JA. Trevino, P. Novak. TS-HDS and FGFR3 antibodies in small fiber neuropathy and Dysautonomia. Muscle Nerve. 2021 Apr 1. Resumen aquí.

V. Fabry et al (A. Pavy-Le Traon). Which Method for Diagnosing Small Fiber Neuropathy?. Front Neurol. 2020; 11: 342. Resumen aquí.

M. G. Porubcin and P. Novak. Diagnostic Accuracy of Electrochemical Skin Conductance in the Detection of Sudomotor Fiber Loss. Front. Neurol., vol. 11, p. 273, avr. 2020. Resumen aquí.

M. Duchesne et al (L. Magy). Assessing sudomotor impairment in patients with peripheral neuropathy: Comparison between electrochemical skin conductance and skin biopsy. Clin Neurophysiol. 2018 Jul;129(7):1341-1348. Resumen aquí.

A. Vinik et al. Normative Values for Electrochemical Skin Conductances and Impact of Ethnicity on Quantitative Assessment of Sudomotor Function. Diabetes Technol Ther. 2016 Jun;18(6):391-8. Resumen aquí.

L. Leclair-Visonneau et al. (Y. Péréon). Electrochemical skin conductance for quantitative assessment of sweat function: Normative values in children. Clinical Neurophysiology Practice 1 (2016) 43–45. Resumen aquí.

L. Bordier et al (B. Bauduceau). Accuracy of a Rapid and Non-Invasive Method for the Assessment of Small Fiber Neuropathy Based on Measurement of Electrochemical Skin Conductances. Front Endocrinol (Lausanne). 2016 Feb 29;7:18. Resumen aquí.

P. Novak. Electrochemical Skin Conductance Correlates with Skin Nerve Fiber Density. Frontiers in Aging Neuroscience. 2016;8. Resumen aquí.

J.P Lefaucheur et al. Diagnosis of small fiber neuropathy: A comparative study of five neurophysiological tests. Neurophysiol Clin. 2015 Dec;45(6):445-55. Resumen aquí.

A. Vinik, M.L Nevoret, C. Casellini. The New Age of Sudomotor Function Testing: A Sensitive and Specific Biomarker for Diagnosis, Estimation of Severity, Monitoring Progression, and Regression in Response to Intervention. Front Endocrinol (Lausanne). 2015 Jun 11;6:94. Resumen aquí.

A.G Smith et al. The diagnostic utility of Sudoscan for distal symmetric peripheral neuropathy. Journal of diabetes and its complications vol. 28,4 (2014): 511-6. Resumen aquí.

C.H Gibbons et al. Capsaicin induces degeneration of cutaneous autonomic nerve fibers. Ann Neurol. 2010;68:888-898. Resumen aquí.

García-Ulloa AC, Almeda-Valdes P, Cuatecontzi-Xochitiotzi TE, et al. Detection of sudomotor alterations evaluated by Sudoscan in patients with recently diagnosed type 2 diabetes. BMJ Open Diab Res Care 2022;10:e003005. doi:10.1136/bmjdrc-2022-003005. Resumen aquí.

Khan A, Pasquier J, Ramachandran V, Ponirakis G, Petropoulos IN, Chidiac O, Thomas B, Robay A, Jayyousi A, Al Suwaidi J, Rafii A, Menzies RA, Talal TK, Najafi-Shoushtari SH, Abi Khalil C, Malik RA. Altered Circulating microRNAs in Patients with Diabetic Neuropathy and Corneal Nerve Loss: A Pilot Study. J Clin Med. 2022 Mar 16;11(6):1632. Resumen aquí.

Gateva A, Kamenov Z. Cardiac Autonomic Neuropathy in Patients with Newly Diagnosed Carbohydrate Disturbances. Horm Metab Res. 2022 May;54(5):308-315. Resumen aquí.

Lin K, Wu Y, Liu S, Huang J, Chen G, Zeng Q. The application of sudoscan for screening microvascular complications in patients with type 2 diabetes. PeerJ. 2022 Mar 14;10:e13089. Resumen aquí.

Kirthi V, Reed KI, Alattar K, Zuckerman BP, Bunce C, Nderitu P, Alam U, Clarke B, Hau S, Al-Shibani F, Petropoulos IN, Malik RA, Pissas T, Bergeles C, Vas P, Hopkins D, Jackson TL. Multimodal testing reveals subclinical neurovascular dysfunction in prediabetes, challenging the diagnostic threshold of diabetes. Diabet Med. 2022 Aug 30 :e14952. Resumen aquí.

Gabriel R, Boukichou-Abdelkader N, Gilis-Januszewska A, Makrilakis K, Gómez-Huelgas R, Kamenov Z, Paulweber B, Satman I, Djordjevic P, Alkandari A, Mitrakou A, Lalic N, Egido J, Más-Fontao S, Calvet JH, Pastor JC, Lindström J, Lind M, Acosta T, Silva L, Tuomilehto J, On Behalf Of The E-Predice Consortium. Reduction in the Risk of Peripheral Neuropathy and Lower Decrease in Kidney Function with Metformin, Linagliptin or Their Fixed-Dose Combination Compared to Placebo in Prediabetes: A Randomized Controlled Trial. J Clin Med. 2023 Mar 3;12(5):2035. Resumen aquí.

G. Ponirakis et al. Painful diabetic neuropathy is associated with increased nerve regeneration in patients with type 2 diabetes undergoing intensive glycemic control. Diabetes Investig. 2021 Mar 13. Resumen aquí.

YR. Lai et al. Feasibility of combining heart rate variability and electrochemical skin conductance as screening and severity evaluation of cardiovascular autonomic neuropathy in type 2 diabetes. J Diabetes Investig. 2021 Jan 31. Resumen aquí.

AM. Wegeberg et al. Cardiac vagal tone as a novel screening tool to recognize asymptomatic cardiovascular autonomic neuropathy: Aspects of utility in type 1 diabetes. Diabetes Res Clin Pract. 2020 Dec;170:108517. Resumen aquí.

II. Hussein, SHA. Alshammary, MSM. Al-Nimer . Assessment of sudomotor function in hypertensive with/without type-2 diabetes patients using SUDOSCAN: An electrophysiological study. Clin Neurophysiol Pract. 2020 Dec 13;6:22-28. Resumen aquí.

DLC. Veloso, RCG. Nascimento, EB. Leite, L. de Avila Santana, AA. Amato. Predictors of sudomotor dysfunction in patients with type 1 diabetes without clinical evidence of peripheral neuropathy. Diabetes Res Clin Pract. 2020 Dec;170:108500. Resumen aquí.

QY. Guo et al. Continuous glucose monitoring defined time-in-range is associated with sudomotor dysfunction in type 2 diabetes. World J Diabetes. 2020 Nov 15;11(11):489-500. Resumen aquí.

A. Syngle, S. Chahal, et K. Vohra. Efficacy and tolerability of DPP4 inhibitor, teneligliptin, on autonomic and peripheral neuropathy in type 2 diabetes: an open label, pilot study. Neurol. Sci., août 2020. Resumen aquí.

D’amato et al. (V. Spallone). The diagnostic usefulness of the combined COMPASS 31 questionnaire and electrochemical skin conductance for diabetic cardiovascular autonomic neuropathy and diabetic polyneuropathy. J Peripher Nerv Syst. 2020 Mar;25(1):44-53. Resumen aquí.

Gatev et al. The role of Sudoscan feet asymmetry in the diabetic foot. Prim. Care Diabetes, vol. 14, no 1, p. 47‑52, févr. 2020. Resumen aquí.

Selvarajah et al. (S. Tesfaye). Diabetic peripheral neuropathy: advances in diagnosis and strategies for screening and early intervention. The Lancet Diab & Endoc, Volume 7, Issue 12, December 2019, 938-948. Resumen aquí.

Carbajal-Ramírez et al. Early identification of peripheral neuropathy based on sudomotor dysfunction in Mexican patients with type 2 diabetes. BMC Neurol. 2019 May 31;19(1):109. Resumen aquí.

Camoin et al. (V. Rigalleau). Comment on Pongrac Barlovic et al. The Association of Severe Diabetic Retinopathy With Cardiovascular Outcomes in Long-standing Type 1 Diabetes: A Longitudinal Follow-up. Diabetes Care 2018;41:2487-2494. Diabetes Care. 2019 Mar;42(3):e4. Resumen aquí.

Travert et al. Lesions of the small fibers of the autonomic nervous system and gradation of the diabetic foot risk in patients with diabetes. Poster, EASD 2019. Póster aquí.

Binns‐Hall et al. (S. Tesfaye). One‐stop microvascular screening service: an effective model for the early detection of diabetic peripheral neuropathy and the high‐risk foot. Diabet Med. 2018 Jul; 35(7): 887–894. Resumen aquí.

Jin et al. The Application of SUDOSCAN for Screening Diabetic Peripheral Neuropathy in Chinese Population. Exp Clin Endocrinol Diabetes. 2018 Sep;126(8):472-477. Resumen aquí.

Poupon et al. (V. Rigalleau). Sudomotor function in diabetic peripheral artery disease: a role for diabetic neuropathy?. Neurol Sci. 2018 Jan;39(1):191-192. Resumen aquí.

B.C Callaghan et al. Better diagnostic accuracy of neuropathy in obesity: A new challenge for neurologists. Clin Neurophysiol. 2018 Mar;129(3):654-66. Resumen aquí.

Goel et al. Comparison of electrochemical skin conductance and vibration perception threshold measurement in the detection of early diabetic neuropathy. PLoS One. 2017 Sep 7;12(9):e0183973. Resumen aquí.

Sheshah et al. Electrochemical skin conductance to detect sudomotor dysfunction, peripheral neuropathy and the risk of foot ulceration among Saudi patients with diabetes mellitus. J Diabetes Metab Disord. 2016; 15: 29. Resumen aquí.

Vinik. Diabetic Sensory and Motor Neuropathy. New England Journal of Medicine. 2016 Apr 14;374(15):1455–64. Resumen aquí.

Selvarajah et al(S. Tesfaye). SUDOSCAN: A Simple, Rapid, and Objective Method with Potential for Screening for Diabetic Peripheral Neuropathy. PLoS One. 2015 Oct 12;10(10):e0138224. Resumen aquí.

A.G Smith et al. The Diagnostic Utility of Sudoscan for Distal Symmetric Peripheral Neuropathy. J Diabetes Complications. 2014 Jul-Aug; 28(4): 511–516. Resumen aquí.

C.M Casellini et al. (A.I Vinik). SUDOSCAN, a non-invasive tool for detecting diabetic small fiber neuropathy and autonomic dysfunction. Diabetes technology and therapeutics. 2013;15(11). Resumen aquí.

C.S Yajnik et al. (J.P Deslypere). Quick and Simple Evaluation of Sudomotor Function for Screening of Diabetic Neuropathy. ISRN Endocrinol. 2012; 2012: 103714. Resumen aquí.

Loser V, et al (Kuntzer T) . Serum neurofilament light chain as a reliable biomarker of hereditary transthyretin-related amyloidosis-A Swiss reference center experience. J Peripher Nerv Syst, 2022 Dec 5. doi: 10.1111/jns.12524. Resumen aquí.

Luigetti M, Di Paolantonio A, Guglielmino V, Romano A, Rossi S, Sabino A, Servidei S, Sabatelli M, Primiano G. Neurofilament light chain as a disease severity biomarker in ATTRv: data from a single-centre experience. Neurol Sci. 2022 Apr;43(4):2845-2848. Resumen aquí.

Galosi E, Leonardi L, Falco P, Di Pietro G, Fasolino A, Esposito N, Leone C, Di Stefano G, Inghilleri M, Luigetti M, Giovanni A, Truini A. Functional and morphometric assessment of small-fibre damage in late-onset hereditary transthyretin amyloidosis with polyneuropathy: the controversial relation between small-fibre-related symptoms and diagnostic test findings. Amyloid. 2022 Sep 12:1-8. Resumen aquí.

Romano A, Guglielmino V, Di Paolantonio A, Bisogni G, Sabatelli M, Della Marca G, Minnella AM, Maceroni M, Bellavia S, Scala I, Sabatelli E, Rollo E, Luigetti M. Pupillometric findings in ATTRv patients and carriers: results from a single-centre experience. Amyloid. 2022 Sep 6:1-6. Resumen aquí.

Campagnolo M, Cacciavillani M, Cipriani A, Salvalaggio A, Castellani F, Pilichou K, Briani C. Peripheral nerve involvement in wild-type transthyretin amyloidosis. Neurol Sci. 2022 Oct 19. Resumen aquí.

M. Kharoubi et al. (T. Damy). Prevalence and prognostic value of autonomic neuropathy assessed by Sudoscan in transthyretin wild-type cardiac amyloidosis. ESC Heart Fail. 2021 Apr;8(2):1656-1665. Resumen aquí.

A. Montcuquet et al. (L. Magy). Electrochemical skin conductance values suggest frequent subclinical autonomic involvement in patients with AL amyloidosis. Amyloid, vol. 27, no 3, p. 215‑216, juill. 2020. Resumen aquí.

E. Fortanier, E. Delmont, A. Verschueren, et S. Attarian. Quantitative sudomotor test helps differentiate transthyretin familial amyloid polyneuropathy from chronic inflammatory demyelinating polyneuropathy. Clin. Neurophysiol., vol. 131, no 5, p. 1129‑1133, mai 2020. Resumen aquí.

I. Conceição et al. Early diagnosis of ATTR amyloidosis through targeted follow-up of identified carriers of TTR gene mutations. Amyloid. 2019 Feb 22;1–7. Resumen aquí.

J.P. Lefaucheur et al. The value of electrochemical skin conductance measurement using Sudoscan in the assessment of patients with familial amyloid polyneuropathy. Clin Neurophysiol. 2018 Aug;129(8):1565-1569. Resumen aquí.

J. Castro et al. Electrochemical skin conductance in hereditary amyloidosis related to transthyretin V30M – a promising tool to assess treatment efficacy?. Amyloid 2018, 25:4, 267-268. Resumen aquí.

L. Obici et al. from the European Network for TTR-FAP (ATTReuNET). Recommendations for presymptomatic genetic testing and management of individuals at risk for hereditary transthyretin amyloidosis. Curr Opin Neurol. 2016 Feb;29 Suppl 1:S27-35. Resumen aquí.

J. Castro et al. The diagnostic accuracy of Sudoscan in transthyretin familial amyloid polyneuropathy. Clin Neurophysiol. 2016 May;127(5):2222-7. Resumen aquí.

A. Rousseau et al. (D. Adams). Potential Role of In Vivo Confocal Microscopy for Imaging Corneal Nerves in Transthyretin Familial Amyloid Polyneuropathy. JAMA Ophthalmol. 2016 Sep 1;134(9):983-9. Resumen aquí.

Huang YC, Huang CC, Lai YR, Lien CY, Cheng BC, Kung CT, Chiang YF, Lu CH. Assessing the Feasibility of Using Electrochemical Skin Conductance as a Substitute for the Quantitative Sudomotor Axon Reflex Test in the Composite Autonomic Scoring Scale and Its Correlation with Composite Autonomic Symptom Scale 31 in Parkinson’s Disease. J Clin Med. 2023 Feb 14;12(4):1517. Resumen aquí.

Georges C, Lloret-Perez S, Ory-Magne F, Fabbri M, Foubert-Samier A, Meissner WG, Rascol O, Pavy-Le Traon A. Alterations in electrochemical skin conductance as a marker of autonomic dysfunction in multiple system atrophy. Parkinsonism Relat Disord. 2022 Aug 28;103:56-59. Resumen aquí.

BS. Gagaouzova et al. Can novel non-invasive autonomic tests help discriminate between pure autonomic failure and multiple system atrophy?. Auton Neurosci. 2021 Mar;231.  Resumen aquí.

C. Popescu. Is sudoscan a reliable tool in detecting small fiber neuropathy in Parkinson’s disease patients?. Neurodegener. Dis. Manag., vol. 10, no 2, p. 81‑93, avr. 2020. Resumen aquí.

Del Pino et al. Autonomic dysfunction is associated with neuropsychological impairment in Lewy body disease. J. Neurol., vol. 267, no 7, p. 1941‑1951, juill. 2020. Resumen aquí.

X. Xu et al (W. Qiu). Clinical utility of SUDOSCAN in predicting autonomic neuropathy in patients with Parkinson’s disease. Parkinsonism Relat Disord. 2019 Jul;64:60-65.  Resumen aquí.

A. Pavy-LeTraon et al. Combined cardiovascular and sweating autonomic testing to differentiate multiple system atrophy from Parkinson’s disease. Neurophysiol Clin. 2018 Apr;48(2):103-110.  Resumen aquí.

A. Al-Qassabi et al. (R.B Postuma). Autonomic Sweat Responses in REM Sleep Behavior Disorder and Parkinsonism. J Parkinsons Dis. 2018;8(3):463-468.  Resumen aquí.

Bellavia S, Scala I, Luigetti M, Brunetti V, Gabrielli M, Zileri Dal Verme L, Servidei S, Calabresi P, Frisullo G, Della Marca G. Instrumental Evaluation of COVID-19 Related Dysautonomia in Non-Critically-Ill Patients: An Observational, Cross-Sectional Study. J Clin Med. 2021 Dec 14;10(24):5861. Resumen aquí.

A. Hinduja, A. Moutairou, JH. Calvet. Sudomotor dysfunction in patients recovered from COVID-19 .Neurophysiol Clin. 2021 Mar;51(2):193-196. Resumen aquí.

ES. Tharwa et al. Sudomotor Changes in Hepatitis C Virus Infection with or without Diabetes Mellitus: A Pilot Study in Egyptian Patients. Am J Trop Med Hyg. 2020 Nov 23;104(2):580-4. Resumen aquí.

S. Ng Wing Tin et al. (J.P Lefaucher). Characterization of Neuropathic Pain in Primary Sjögren’s Syndrome with Respect to Neurophysiological Evidence of Small-Fiber Neuropathy. Pain Med. 2019 May 1;20(5):979-987. Resumen aquí.

H.G Zouari et al (J.P Lefaucher). The Clinical Features of Painful Small-Fiber Neuropathy Suggesting an Origin Linked to Primary Sjögren’s Syndrome. Pain Pract. 2019 Apr;19(4):426-434. Resumen aquí.

P. Sahuc et al. Sudoscan as a noninvasive tool to assess sudomotor dysfunction in patients with Fabry disease: results from a case–control study. Ther Clin Risk Manag. 2016 Feb 2;12:135-8. Resumen aquí.

Wang Y, Cai RJ, Yang JH, Wang YA, Xiao H, Wu Y, Bao Y, Yan Y, Zhu Z, Chen F, Pi CX, Tan QL, Zhang YY, Tian XK, Wang T, Zhe XW. Electrochemical skin conductance and heart rate variability in patients with non-dialysis chronic kidney disease. J Electrocardiol. 2023 Jan 21;78:34-38. Resumen aquí.

Touzot M, Pauline Reach P et al. Association of Electrochemical Skin Conductance by Sudoscan and Cardiovascular Outcomes in Hemodialysis Patients. Kidney Int Rep. 2022 Dec; 7(12): 2734–2736. Resumen aquí.

F. Izzi et al. Autonomic functions in focal epilepsy: A comparison between lacosamide and carbamazepine monotherapy , J. Neurol. Sci., vol. 418, p. 117095, nov. 2020. 2016 Feb 2;12:135-8. Resumen aquí.

Dumolard A, Jean-Pascal Lefaucheur, Payen JP, Hodaj H. Central Sensitization and Small-fiber Neuropathy Are Associated in Patients With Fibromyalgia. Clin J Pain2023 Jan 1;39(1):8-14. Resumen aquí.

G. Pickering et al. Electrochemical skin conductance and Quantitative Sensory Testing on Fibromyalgia. Pain Pract., vol. 20, no 4, p. 348‑356, avr. 2020. Resumen aquí.

Del Pino et al. Autonomic dysfunction is associated with neuropsychological impairment in Lewy body disease. J. Neurol., vol. 267, no 7, p. 1941‑1951, juill. 2020. Resumen aquí.

A. Silvani. Autonomic nervous system dysfunction in narcolepsy type 1: time to move forward to the next level?. Clin Auton Res. 2020 Dec;30(6):501-502. Resumen aquí.

C. Rocchi et al. Autonomic symptoms, cardiovascular and sudomotor evaluation in de novo type 1 narcolepsy. Clin. Auton. Res., août 2020. Resumen aquí.

CC. Zwack et al. Does autonomic nervous system dysfunction influence cardiovascular disease risk in young adults with intellectual disability?. Am J Physiol Heart Circ Physiol. 2021 Feb 1;320(2):H891-H900. Resumen aquí.

BS. Gagaouzova et al. Can novel non-invasive autonomic tests help discriminate between pure autonomic failure and multiple system atrophy?. Auton Neurosci. 2021 Mar;231. Resumen aquí.

JA. Trevino, P. Novak. TS-HDS and FGFR3 antibodies in small fiber neuropathy and Dysautonomia. Muscle Nerve. 2021 Apr 1. Resumen aquí.

Frachet S, Danigo A, Labriffe M, Bessaguet F, Quinchard B, Deny N, Baffert KA, Deluche E, Sturtz F, Demiot C, Magy L Renin-Angiotensin-System Inhibitors for the Prevention of Chemotherapy-Induced Peripheral Neuropathy: OncoToxSRA, a Preliminary Cohort Study. J Clin Med. 2022 May 23;11(10):2939. Resumen aquí.

Mahfouz FM, Park SB, Li T, Timmins HC, Horvath LG, Harrison M, Grimison P, King T, Goldstein D, Mizrahi D. Association of electrochemical skin conductance with neuropathy in chemotherapy-treated patients. Clin Auton Res. 2022 Sep 21. Resumen aquí.

J.B Delmotte et al. Electrochemical Skin Conductance as a Marker of Painful Oxaliplatin-Induced Peripheral Neuropathy. Neurol Res Int. 2018; 2018: 1254602. Resumen aquí.

M. Saad et al (D. Ricard). Quick, non-invasive and quantitative assessment of small fiber neuropathy in patients receiving chemotherapy. Journal of Neuro-Oncology. 2016;127(2):373-380. Resumen aquí.

Andrea L, Wai-Chi F, Xue L, Risa O, Harriet C, Rebecca W, Wing-Yee S, Francis C, Juliana C. The Clinical Utility of SUDOSCAN in Chronic Kidney Disease in Chinese Patients with Type 2 Diabetes. PLOS ONE DOI:10.1371/journal.pone.0134981 August 13, 2015. Resumen aquí.

Lee Ling L, Amy F, Eric L, Risa O, Kitty C, Ronald M, Andrea L, Juliana C, Alice K. Sudomotor dysfunction independently predicts incident cardiovascular-renal events and all-cause death in type 2 diabetes: the Joint Asia Diabetes Evaluation register. Nephrol Dial Transplant (2019) 34: 1320–1328. Resumen aquí.

Lin K, Wu Y, Liu S, Huang J, Chen G, Zeng Q. The application of sudoscan for screening microvascular complications in patients with type 2 diabetes. PeerJ. 2022 Mar 14;10:e13089. Resumen aquí.

Wang Y, Cai RJ, Yang JH, Wang YA, Xiao H, Wu Y, Bao Y, Yan Y, Zhu Z, Chen F, Pi CX, Tan QL, Zhang YY, Tian XK, Wang T, Zhe XW. Electrochemical skin conductance and heart rate variability in patients with non-dialysis chronic kidney disease. J Electrocardiol. 2023 Jan 21;78:34-38. Resumen aquí.

Touzot M, Pauline Reach P et al. Association of Electrochemical Skin Conductance by Sudoscan and Cardiovascular Outcomes in Hemodialysis Patients. Kidney Int Rep. 2022 Dec; 7(12): 2734–2736. Resumen aquí.

Hinduja A et al. Improvement in small fiber neuropathy after a gluten-free diet, demonstrated in a patient with celiac disease by measurement of electrochemical skin conductance. Neurophysiol Clin. 2022 Oct 6:S0987-7053(22)00084-3. Resumen aquí.

T. Didangelos et al. Vitamin B12 Supplementation in Diabetic Neuropathy: A 1-Year, Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients. 2021 Jan 27;13(2):395. Resumen aquí.

C.S. Yajnik et al. A physiological dose of oral vitamin B-12 improves hematological, biochemical-metabolic indices and peripheral nerve function in B-12 deficient Indian adolescent women. PLoS One. 2019;14(10):e0223000. Published 2019 Oct 10. Resumen aquí.

A.P. Trouvin and S. Perrot. Functional and histological improvements of small nerve neuropathy after high-concentration capsaicin patch application: A case study. Pain Rep. 2019;4(4):e761. Resumen aquí.

C.M. Casellini et al. (A. Vinik). Bariatric Surgery Restores Cardiac and Sudomotor Autonomic C-Fiber Dysfunction towards Normal in Obese Subjects with Type 2 Diabetes. PLoS One. 2016 May 3;11(5):e0154211. Resumen aquí.

A. Raisanen et al. (J. Tuomilehto). Sudomotor Function as a Tool for Cardiorespiratory Fitness Level Evaluation: Comparison with Maximal Exercise Capacity. Int J Environ Res Public Health. 2014 May 30;11(6):5839-48. Resumen aquí.